Author

Kevin Li

UC San Diego Health SystemORCID 0000-0002-6790-0180Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Kevin Li2 papers · Duke University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Alexei MartsinkovskiyiD· 1 shared Andrew M. LowyiD· 1 shared Asimina S. CourelliiD· 1 shared Evangeline Sari. MoseiD· 1 shared Hervé TiriaciD· 1 shared Isabella NgiD· 1 shared James LeeiD· 1 shared Jay PateliD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexei MartsinkovskiyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintDec 3, 2024

SUMO Inhibition Plus CD40 Agonism Increases Anti-Tumor Immunogenicity Through Interferon Mediated Macrophage Activation

Kevin Li, Asimina S. Courelli, James Lee…·Andrew M. Lowy

This study shows that combining SUMO inhibition with CD40 agonism enhances anti-tumor immunogenicity in PDAC by improving macrophage function and T-cell infiltration, leading to improved survival in a mouse model.

1 citation

mouseexperimental assay

𝕏 PostBluesky